7项新国标落地新兴产业，外资加大关注A股电子与创新药板块！科创综指ETF华夏（589000）近1周日均成交额领先同类！

Group 1 - The Shanghai Stock Exchange Science and Technology Innovation Board Composite Index (000680) increased by 0.25% as of July 3, 2025, with notable stock performances including ShenZhou Cell reaching the daily limit, Huiyu Pharmaceutical rising by 10.40%, and Nearshore Protein up by 8.83% [1] - The Huaxia Science and Technology Innovation Index ETF (589000) saw a 2.55% increase over the past two weeks, with a recent price of 0.97 yuan [1] - The Huaxia Science and Technology Innovation Index ETF experienced a significant growth in scale, increasing by 1.09 billion yuan over the past three months, ranking first among comparable funds [1] Group 2 - A total of 643 foreign institutions conducted research on 4,835 A-share companies as of July 2, with high interest in the electronics, pharmaceutical, and machinery sectors [2] - Key topics of interest for foreign investors this year include AI applications, humanoid robot development, innovative drug research, dividends, and merger plans [2] - The Huaxia Science and Technology Innovation Index ETF is positioned as a crucial tool for investors to capitalize on growth opportunities in cutting-edge fields such as artificial intelligence and commercial aerospace, supported by recent regulatory policies [2]